Provention Bio, Inc., (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Provention Bio Inc. (PRVB) Prices 5M Share Common Offering at $8/ShSeptember 19, 2019 5:42 AM Provention Bio Announces Proposed Public Offering of Common StockSeptember 18, 2019 4:14 PM